Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Chem Biol Drug Des ; 79(6): 943-9, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22321778

ABSTRACT

The inherent morbidity and mortality caused by schistosomiasis is a serious public health problem in developing countries. Praziquantel is the only drug in therapeutic use, leading to a permanent risk of parasite resistance. In search for new schistosomicidal drugs, meclonazepam, the 3-methyl-derivative of clonazepam, is still considered an interesting lead-candidate because it has a proven schistosomicidal effect in humans but adverse effects on the central nervous system did not allow its clinical use. Herein, the synthesis, in vitro biological evaluation, and molecular modeling of clonazepam, meclonazepam, and analogues are reported to establish the first structure-activity relationship for schistosomicidal benzodiazepines. Our findings indicate that the amide moiety [N(1) H-C(2) (=O)] is the principal pharmacophoric unit of 1,4-benzodiazepine schistosomicidal compounds and that substitution on the amide nitrogen atom (N(1) position) is not tolerated.


Subject(s)
Benzodiazepines/chemistry , Benzodiazepinones/chemistry , Clonazepam/chemistry , Schistosomicides/chemical synthesis , Animals , Benzodiazepines/chemical synthesis , Benzodiazepines/pharmacology , Benzodiazepinones/chemical synthesis , Benzodiazepinones/pharmacology , Clonazepam/chemical synthesis , Clonazepam/pharmacology , Humans , Models, Molecular , Schistosoma/drug effects , Schistosomiasis/parasitology , Schistosomiasis/pathology , Schistosomicides/chemistry , Schistosomicides/pharmacology , Structure-Activity Relationship
2.
Org Biomol Chem ; 9(16): 5737-47, 2011 Aug 21.
Article in English | MEDLINE | ID: mdl-21717023

ABSTRACT

A conjugable analogue of the benzodiazepine 5-(2-hydroxyphenyl)-7-nitro-benzo[e][1,4]diazepin-2(3H)-one containing a bromide C(12)-aliphatic chain (BDC) at nitrogen N1 was synthesized. One-pot preparation of this benzodiazepine derivative was achieved using microwave irradiation giving 49% yield of the desired product. BDC inhibited FNZ binding to GABA(A)-R with an inhibition binding constant K(i) = 0.89 µM and expanded a model membrane packed up to 35 mN m(-1) when penetrating in it from the aqueous phase. BDC exhibited surface activity, with a collapse pressure π = 9.8 mN m(-1) and minimal molecular area A(min) = 52 Å(2)/molecule at the closest molecular packing, resulted fully and non-ideally mixed with a phospholipid in a monolayer up to a molar fraction x≅ 0.1. A geometrical-thermodynamic analysis along the π-A phase diagram predicted that at low x(BDC) (<0.1) and at all π, including the equilibrium surface pressures of bilayers, dpPC-BDC mixtures dispersed in water were compatible with the formation of planar-like structures. These findings suggest that, in a potential surface grafted BDC, this compound could be stabilize though London-type interactions within a phospholipidic coating layer and/or through halogen bonding with an electron-donor surface via its terminal bromine atom while GABA(A)-R might be recognized through the CNZ moiety.


Subject(s)
Benzodiazepines/chemistry , Benzodiazepines/metabolism , Bromine/chemistry , Receptors, GABA-A/isolation & purification , Receptors, GABA-A/metabolism , Animals , Benzodiazepines/chemical synthesis , Cattle , Clonazepam/chemical synthesis , Clonazepam/chemistry , Clonazepam/metabolism , GABA Modulators/chemical synthesis , GABA Modulators/chemistry , GABA Modulators/metabolism , Halogenation , Lipid Bilayers/metabolism , Phospholipids/metabolism , Protein Binding , Surface Properties , Synaptic Membranes/metabolism , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL